Skip to main content
Log in

Mass rotavirus vaccination, a cost-effective strategy in India

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Rose J, Hawthorn RL, Watts B, Singer ME.Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis. BMJ 339: 787-791, No. 7724, 3 Oct 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mass rotavirus vaccination, a cost-effective strategy in India. Pharmacoecon. Outcomes News 588, 6 (2009). https://doi.org/10.2165/00151234-200905880-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905880-00007

Keywords

Navigation